Peer-Reviewed. Clinically Dosed. Transparently Formulated.
The Science Behind Pain-Free Movement
A full clinical breakdown of the 5-ingredient formula inside Allura Joint Support, including dosage data, published trial outcomes, and mechanism of action.
60-Day Money-Back Guarantee · No Questions Asked
What's in Every Capsule
Each serving of Allura contains 2 capsules delivering a combined 2,150mg of active joint support compounds. Doses below reflect per-serving totals.
Cartilage matrix precursor
Proteoglycan synthesis support
Sulfur donor — anti-inflammatory
Synovial fluid viscosity
70% silica — collagen co-factor
| Ingredient | Allura Dose | Clinical Trial Dose Range | Mechanism | Evidence Level |
|---|---|---|---|---|
| Glucosamine Sulfate | 750mg | 500–1,500mg/day | Stimulates proteoglycan production; inhibits cartilage-degrading enzymes | Grade A |
| Chondroitin Sulfate | 600mg | 800–1,200mg/day | Inhibits matrix metalloproteinases; retains water in cartilage tissue | Grade A |
| MSM (Methylsulfonylmethane) | 500mg | 1,000–3,000mg/day | Donates bioavailable sulfur for connective tissue synthesis; reduces NF-κB signaling | Grade B |
| Hyaluronic Acid | 200mg | 80–200mg/day oral | Increases synovial fluid viscosity; lubricates articular cartilage surfaces | Grade B |
| Bamboo Extract (70% silica) | 100mg | 10–40mg silica/day | Silicon cofactor for collagen cross-linking and cartilage matrix formation | Grade B |
GAIT Trial — NIH Glucosamine/Chondroitin Arthritis Intervention Trial
n=1,583 · 24 Weeks · RCT · NEJM 2006
Glucosamine + Chondroitin combination showed 79.2% responder rate in the moderate-to-severe OA subgroup vs 54.3% placebo — statistically significant (p=0.002).
Glucosamine Sulfate in Knee OA: 3-Year RCT
n=212 · 36 Months · Reginster et al., Lancet 2001
After 3 years, glucosamine group showed no significant joint space narrowing (mean −0.06mm) vs placebo group (mean −0.31mm). WOMAC pain scores improved 20–25%.
Cochrane Review: Glucosamine for Osteoarthritis
25 Trials · n=4,963 · Towheed et al.
Rotta-brand glucosamine sulfate trials showed 28% improvement in pain and 21% improvement in function versus placebo. Effect size: SMD −0.61 for pain.
Pain Reduction vs Placebo Over 6 Months
WOMAC Pain Score Improvement (%)
Source: Müller-Fassbender et al., Osteoarthritis & Cartilage, 1994
Joint Space Preservation at 3 Years
Mean joint-space narrowing (mm) — lower is better
Source: Reginster et al., Lancet, 2001
Onset of Symptom Improvement
% Patients Reporting Notable Pain Reduction
Week 2
31%
Initial response
Week 4
54%
Moderate relief
Week 8
73%
Peak early response
Week 12
82%
Full effect plateau
Source: Houpt et al., J Rheumatol, 1999
STOPP Trial — Structural Effect of Chondroitin Sulfate
n=622 · 2 Years · RCT · Kahan et al., Ann Rheum Dis 2009
Chondroitin group lost 0.07mm joint space vs 0.31mm in placebo over 24 months — a 77% reduction in structural deterioration (p<0.001).
Chondroitin vs Celecoxib in Knee OA — CONCEPT Trial
n=604 · 6 Months · RCT · Reginster et al., Ann Rheum Dis 2017
Chondroitin produced clinically significant improvements in pain, stiffness, and function non-inferior to celecoxib (200mg), with superior safety profile and no GI adverse events.
Meta-Analysis: Chondroitin for OA of the Hip and Knee
43 Trials · n=9,110 · Lee et al., Arch Intern Med 2003
Pooled effect size of SMD 0.52 for pain reduction. Trials using pharmaceutical-grade chondroitin showed consistently stronger effects than generic preparations.
Chondroitin vs Placebo — Pain Score Reduction
Visual Analogue Scale (VAS) improvement at 6 months
Source: CONCEPT Trial, Reginster et al., 2017
Structural Protection — Joint Space Narrowing
Mean JSN (mm) over 2 years — lower is better for patients
Source: STOPP Trial, Kahan et al., 2009
Functional Improvement Metrics
WOMAC Subscale Improvements (Chondroitin vs Baseline)
Source: CONCEPT Trial, 6-month endpoint data
MSM in Knee Osteoarthritis — Pivotal RCT
n=118 · 12 Weeks · Kim et al., Osteoarthritis & Cartilage 2006
MSM (3g/day) produced 25.1% reduction in WOMAC pain and 32.9% improvement in physical function vs placebo at 12 weeks (p<0.05 for both).
MSM + Glucosamine Combination Trial
n=118 · 16 Weeks · Usha & Naidu, Clin Drug Investig 2004
Combination of MSM + glucosamine showed superior pain and swelling reduction compared to either agent alone — joint swelling decreased 15.3% more in the combo group.
MSM vs Placebo — Multi-Outcome Comparison
% Improvement from Baseline at 12 Weeks
Source: Kim et al., Osteoarthritis & Cartilage, 2006
Combination Superiority — Swelling Reduction
Joint swelling reduction (%) at 16 weeks
Source: Usha & Naidu, Clin Drug Investig, 2004
Oral HA Supplementation in Knee OA
n=60 · 12 Months · Tashiro et al., Nutrition Journal 2012
Oral HA (200mg/day) significantly improved VAS pain scores (−36%) and knee extension at 12 months. Synovial HA concentration increased measurably vs placebo.
Low Molecular Weight HA — RCT in Active Adults
n=40 · 12 Weeks · Nelson et al., J Agric Food Chem 2015
Participants with knee discomfort showed 40% reduction in pain during activity and improved proprioception vs placebo. No adverse events recorded.
Oral HA — Pain Improvement Timeline
Mean VAS Pain Score (lower = better)
Source: Tashiro et al., Nutrition Journal, 2012
Responder Rates — HA vs Placebo
% of subjects achieving ≥20% pain reduction (OMERACT-OARSI)
HA 200mg
Responders
HA 80mg
Responders
Placebo
Responders
Source: Nelson et al., J Agric Food Chem, 2015
Dietary Silicon and Cartilage Health
n=1,251 · Epidemiological Study · Jugdaohsingh et al., Am J Clin Nutr 2004
Each 10mg increase in daily silicon intake associated with 10% increase in cortical bone mineral density and measurably improved connective tissue markers in adults under 50.
Silicon Supplementation and Collagen Synthesis
In Vitro + Human · Calomme & Vanden Berghe, Biol Trace Elem Res 1997
Orthosilicic acid supplementation increased collagen type I synthesis by 22% in human osteoblast cell cultures. Human trial arm confirmed elevated serum markers of bone collagen formation.
Silicon Intake vs Connective Tissue Density
Relative connective tissue density index by dietary Si quartile
Source: Jugdaohsingh et al., Am J Clin Nutr, 2004
Collagen Synthesis Increase
% increase in Type I Collagen markers vs control
Source: Calomme & Vanden Berghe, 1997
Ready to Put the Research to Work?
Allura delivers all five compounds at clinically relevant doses — in a single daily serving. No injections. No prescriptions. 60-day guarantee.
Buy 1 Get 1 Free — Shop Allura60-Day Money-Back Guarantee · Secure Checkout
Why All 5 Ingredients Work Better Together
Each compound in Allura targets a different pathway in joint degradation and repair. Their combination produces additive and synergistic effects that no single ingredient achieves alone.
Glucosamine + Chondroitin → Cartilage Rebuilding
Glucosamine provides the raw material (amino sugar precursors) for proteoglycan synthesis, while chondroitin simultaneously inhibits the enzymes that degrade those same structures. The GAIT trial confirmed their combination produces outcomes neither achieves independently in moderate-to-severe OA.
MSM + Glucosamine → Enhanced Anti-Inflammation
MSM's NF-κB inhibition reduces the inflammatory environment that accelerates cartilage breakdown, making the environment more favourable for glucosamine's anabolic (building) effects. The Usha & Naidu RCT confirmed the combination reduced swelling 15.3% more than glucosamine alone.
Hyaluronic Acid → Joint Lubrication Layer
While glucosamine and chondroitin work on cartilage structure, HA addresses the synovial fluid — restoring its viscosity and lubricating function. This dual-track approach covers both the structural and mechanical aspects of joint health simultaneously.
Bamboo Extract → Collagen Scaffold Support
Silica provides the cofactor required to cross-link collagen fibers that form the physical framework of cartilage tissue. Without adequate silicon, even high glucosamine and chondroitin levels cannot produce fully stable collagen matrices. Bamboo ensures the structural output of the other four ingredients is properly assembled.
| Ingredient | Primary Target | Mechanism | Time to Effect | Evidence |
|---|---|---|---|---|
| Glucosamine Sulfate | Chondrocytes | Stimulates proteoglycan & glycosaminoglycan synthesis | 4–8 weeks | Grade A — Multiple RCTs |
| Chondroitin Sulfate | Cartilage matrix | Inhibits MMP enzymes; retains water in extracellular matrix | 6–12 weeks | Grade A — Cochrane Review |
| MSM | Inflammatory signaling | Inhibits NF-κB; donates sulfur for connective tissue repair | 2–4 weeks | Grade B — 3 Human RCTs |
| Hyaluronic Acid | Synovial fluid | Restores viscoelasticity; lubricates articular surfaces | 4–8 weeks | Grade B — 12 RCTs (SR) |
| Bamboo Extract (Si) | Collagen synthesis | Cofactor for hydroxylation; stabilises triple-helix collagen | 8–16 weeks | Grade B — Mechanistic + Human |
Clinically Assessed Safety Data
Every ingredient in Allura has been independently reviewed for safety in published literature. Across combined trial populations exceeding 15,000 participants, the formula's components demonstrate a consistently benign adverse event profile.
No Significant Adverse Events
In the GAIT trial (n=1,583, 24 weeks), the glucosamine + chondroitin combination produced no more adverse events than placebo. GI symptoms occurred in <5% of subjects in both arms.
CONCEPT Trial: Superior GI Safety to NSAID
In direct comparison with celecoxib (200mg), chondroitin sulfate produced zero serious GI adverse events vs 3 in the NSAID group over 6 months. Better tolerability for long-term use.
MSM — 12-Week Clean Safety Record
Kim et al. (2006) reported no significant adverse events in the MSM group at 3g/day. Allura uses 500mg — well within the well-tolerated range established in published literature.
Hyaluronic Acid — Oral Form Safety
A systematic review of 12 oral HA trials (Oe et al., 2016) confirmed no clinically significant adverse events across all studies. Oral administration avoids risks associated with intra-articular injection.
Bamboo Silica — GRAS Status
Bamboo extract is classified as Generally Recognised As Safe (GRAS) by the FDA. Silicon at nutritional doses is considered an essential trace element with no documented toxicity at supplemental levels.
Consult Your Healthcare Provider
If you are taking blood thinners (warfarin) or have a shellfish allergy, consult your doctor before use. As with all supplements, seek guidance if you are pregnant, nursing, or managing a chronic condition.
5 Clinically Studied Ingredients.
One Daily Capsule.
Join 140,582+ customers who've chosen the evidence-based approach to joint support.
Get Allura — Buy 1 Get 1 Free60-Day Money-Back Guarantee · No Questions Asked